Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Souvenaid

- PMLiVE

Open Road boosts healthcare offering

Communications specialist hires senior consultant for its healthcare team

- PMLiVE

Taking contract research’s pulse

The last 12 months have seen the cost-cutting drive sweeping through the pharma industry move beyond sales, administration and manufacturing and start to affect R&D

Novartis building

CHMP denies Novartis’ heart failure drug

Panel refuses to recommend serelaxin for use in EU

- PMLiVE

Otsuka/Lundbeck say brexpiprazole works in phase III trial

On course as successor to antipsychotic Abilify

- PMLiVE

GSK’s diabetes drug among CHMP recommendations

EMA committee also backs drugs from Bayer, Takeda and Linepharma France

Theravance hires BMS veteran Pasqualone

He joins as senior VP, operations

Bristol-Myers Squibb (BMS) building

BMS shares fall on nivolumab jitters despite solid Q4 results

Awaiting data from ongoing studies before advancing cancer prospect

Small diseases need big picture communications

An early commitment to communications planning in rare diseases is worth the risk

- PMLiVE

Tablet detailing

As customer expectations increase, so must pharma's approach

Novartis building

CHMP backs Xolair for severe hives

Novartis set to expand indications for asthma drug

J&J expected to make best use of digital in 2014

Company's strong approach to marketing strategy praised in Digital Futures 2014 survey

- PMLiVE

NICE set to extend MabThera recommendation

Says Roche’s drug can be used on NHS to treat two serious forms of vasculitis

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links